Christopher Gerner

Full Professor

Austria

Research Interests

Explore related searches

Professors in Austria Professors in Cancer Biology Cancer Biology professors in Austria

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Christopher Gerner is a Full Professor at the University of Vienna, Chemical Faculty, in Austria. His research focuses on proteomic analysis, particularly in the context of cancer resistance mechanisms, as well as the effects of various treatments on plasma proteomics. His recent work also includes the exploration of lipid-based nanoparticle interactions in microglia and the optimization of techniques for phosphoproteomics.

Articles (17)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (18)

Lukas Janker

Lab Head - Principal Scientist

AUSTRIA

Christopher Gerner

Research Interests

Explore related searches

Contact this professor

About

Articles (17)

Proteomic Analysis of FFPE Tissue Samples Identifies Potential Molecular Mechanisms Mediating Resistance to Radiotherapy in Rectal Cancer

Time Course of Plasma Proteomic and Oxylipin Changes Induced by LPS Challenge and Modulated by Antioxidant Supplementation in a Randomized Controlled Trial

Mass spectrometry-based analysis of eccrine sweat supports predictive, preventive and personalised medicine in a cohort of breast cancer patients in Austria

Plasma Instead of Serum Avoids Critical Confounding of Clinical Metabolomics Studies by Platelets

Systematic Optimization of Automated Phosphopeptide Enrichment for High-Sensitivity Phosphoproteomics

Lipid-nanoparticle-induced vacuolization in microglia

RiboScreen<sup>TM</sup> Technology Delivers a Ribosomal Target and a Small-Molecule Ligand for Ribosome Editing to Boost the Production Levels of Tropoelastin, the Monomeric Unit of Elastin

Primary and hTERT-Transduced Mesothelioma-Associated Fibroblasts but Not Primary or hTERT-Transduced Mesothelial Cells Stimulate Growth of Human Mesothelioma Cells

Exploring the Potential of Metal‐Based Candidate Drugs as Modulators of the Cytoskeleton

Aberrant DNA Methylation, Expression, and Occurrence of Transcript Variants of the ABC Transporter <i>ABCA7</i> in Breast Cancer

Impact of Bariatric Surgery on the Stability of the Genetic Material, Oxidation, and Repair of DNA and Telomere Lengths

A Practical and Analytical Comparative Study of Gel-Based Top-Down and Gel-Free Bottom-Up Proteomics Including Unbiased Proteoform Detection

Gendered burial practices of early Bronze Age children align with peptide-based sex identification: A case study from Franzhausen I, Austria

An Anticancer Rhenium Tricarbonyl Targets Fe−S Cluster Biogenesis in Ovarian Cancer Cells

Eine tumor‐inhibierende Rheniumtricarbonylverbindung beeinflusst die Biogenese des Fe−S Clusters

INTERCEPT Pathogen Reduction in Platelet Concentrates, in Contrast to Gamma Irradiation, Induces the Formation of <i>trans</i>-Arachidonic Acids and Affects Eicosanoid Release during Storage

Metabolic phenotyping of tear fluid as a prognostic tool for personalised medicine exemplified by T2DM patients

Collaborators (18)

Lukas Janker

Andrea Bileck

Margit Cichna-Markl

Maria Zellner

Jesper Olsen

Fabian Kanz

Katharina Rebay-Salisbury

Norbert Mueller

Margarethe Geiger

Lukas Skos

Walter Berger

Astrid Slany

Jae-Won Yang

Balazs Dome

Yasmin Borutzki

Samuel M. Meier‐Menches

Michael Grusch

Martin Schreiber

Make your next move.